Analyst Reco. Collegium Pharmaceutical, Inc.

Equities

COLL

US19459J1043

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
36.42 ^USD	+1.62%		+4.54%	+18.32%

Apr. 11	Collegium Pharmaceutical to Redeem $26.35 Million of Senior Notes	MT
Feb. 26	Piper Sandler Adjusts Price Target on Collegium Pharmaceutical to $39 From $37, Maintains Overweight Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Piper Sandler Adjusts Price Target on Collegium Pharmaceutical to $39 From $37, Maintains Overweight Rating	Feb. 26	MT
Truist Adjusts Price Target on Collegium Pharmaceutical to $40 From $37, Maintains Buy Rating	Feb. 26	MT
Truist Adjusts Collegium Pharmaceutical's Price Target to $37 From $31, Keeps Buy Rating	Jan. 04	MT
Jefferies Downgrades Collegium Pharmaceutical to Hold From Buy, Raises Price Target to $37 From $30	Jan. 04	MT
Needham Adjusts Price Target on Collegium Pharmaceutical to $36 From $35, Maintains Buy Rating	23-08-25	MT
Jefferies Assumes Collegium Pharmaceutical at Buy With $30 Price Target	23-05-02	MT
Needham Adjusts Price Target on Collegium Pharmaceutical to $35 From $34, Maintains Buy Rating	23-01-05	MT
Needham Adjusts Price Target on Collegium Pharmaceutical to $34 From $36, Maintains Buy Rating	22-11-04	MT
HC Wainwright Downgrades Collegium Pharmaceutical to Neutral From Buy	22-08-08	MT
Needham Adjusts Collegium Pharmaceutical's Price Target to $36 From $34, Keeps Buy Rating	22-04-06	MT
Piper Sandler Adjusts Collegium Pharmaceutical's Price Target to $42 From $36, Reiterates Overweight Rating	22-02-22	MT
Needham Adjusts Collegium Pharmaceutical's Price Target to $34 From $28, Reiterates Buy Rating	22-02-15	MT
HC Wainwright Adjusts Collegium Pharmaceutical's Price Target to $29 From $26, Reiterates Buy Rating	22-02-15	MT
Cantor Fitzgerald Upgrades Collegium Pharmaceutical to Overweight From Neutral; Price Target is $26	22-02-15	MT
Needham Adjusts Price Target on Collegium Pharmaceutical to $28 from $26, Keeps Buy Rating	21-11-15	MT
HC Wainwright Adjusts Collegium Pharmaceutical PT to $26 From $28, Maintains Buy Rating	21-11-05	MT
Needham Adjusts Price Target on Collegium Pharmaceutical to $26 From $32, Maintains Buy Rating	21-11-05	MT
COLLEGIUM PHARMACEUTICAL : Cantor Fitzgerald Downgrades Collegium Pharmaceutical to Neutral from Overweight, Adjusts Price Target to $22 from $30	21-08-06	MT
COLLEGIUM PHARMACEUTICAL : HC Wainwright Adjusts Collegium Pharmaceutical's Price Target to $28 From $33, Maintains Buy Rating	21-08-06	MT
COLLEGIUM PHARMACEUTICAL : HC Wainwright Adjusts Collegium Pharmaceutical's Price Target to $29 from $31, Maintains Buy Rating	20-11-09	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Collegium Pharmaceutical, Inc.

Equities

COLL

US19459J1043

Analyst Reco.

Filters